Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

66.58
-0.3700-0.55%
Post-market: 66.47-0.1103-0.17%19:55 EDT
Volume:5.54M
Turnover:368.73M
Market Cap:135.54B
PE:14.66
High:66.84
Open:66.77
Low:66.19
Close:66.95
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.82
T/O Rate:0.27%
Dividend:2.51
Dividend Rate:3.77%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:6.07
PE(LYR):19.24

Loading ...

Bristol-Myers Squibb Company - Bms Expects to Create 2,000 Construction and Indirect Jobs Between 2027–2030

THOMSON REUTERS
·
Aug 10

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

THOMSON REUTERS
·
Aug 10

Bristol Myers to Build $2.3 Billion Manufacturing Site in Houston

Reuters
·
Aug 10

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Dow Jones
·
Aug 08

Bristol-Myers Squibb Tracks Real-World Use of Luspatercept in Anemia Care

TIPRANKS
·
Aug 08

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Dow Jones
·
Aug 07

CytomX Q2 Revenue Misses, Partly Hurt by Lower Research Activities in the Astellas Collaboration

Reuters
·
Aug 07

Prothena Publishes Corporate Overview Presentation on Protein-Dysregulation Drug Pipeline

Reuters
·
Aug 07

US FDA Approves Replimune's Skin Cancer Drug

Reuters
·
Aug 07

Prothena: May Earn $55 Mln Clinical Milestone Payment if Bristol Myers Squibb Decides to Advance Prx019 ; Bms Decision Expected Year End 2026

THOMSON REUTERS
·
Aug 07

Deal or no Deal, AstraZeneca Stock is a Bargain

Dow Jones
·
Aug 06

Bristol Myers Squibb (BMY) Stock Looks Reasonable Below Fair Value

Simply Wall St.
·
Aug 06

Bristol-Myers Squibb (BMY) Gets a Hold from RBC Capital

TIPRANKS
·
Aug 06

FTSE 100 Rises, Led by Glencore, Next Earnings; Banks Slide

Reuters
·
Aug 06

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports

TIPRANKS
·
Aug 05

Movement Alert|Bristol-Myers Squibb Falls 3.19% in Regular Trading, Insiders Deny AstraZeneca Merger Talks

Market Focus
·
Aug 05

Market Chatter: AstraZeneca, Bristol Myers Not Pursuing Merger Talks

MT Newswires Live
·
Aug 05

Schrodinger Signs Strategic Collaboration, Software Agreement with Bristol Myers Squibb for Bunsen AI Co-Scientist Deployment

Reuters
·
Aug 05

Bristol Myers Shares Down 2% Premarket After Reuters Reports 'No Discussions' over AstraZeneca Deal

THOMSON REUTERS
·
Aug 05